1. Home
  2. MYNZ vs SSKN Comparison

MYNZ vs SSKN Comparison

Compare MYNZ & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mainz Biomed N.V.

MYNZ

Mainz Biomed N.V.

HOLD

Current Price

$1.23

Market Cap

8.8M

Sector

Health Care

ML Signal

HOLD

Logo Strata Skin Sciences Inc.

SSKN

Strata Skin Sciences Inc.

HOLD

Current Price

$1.24

Market Cap

8.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYNZ
SSKN
Founded
2021
1989
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8M
8.9M
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
MYNZ
SSKN
Price
$1.23
$1.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$14.00
$6.00
AVG Volume (30 Days)
197.9K
69.5K
Earning Date
12-29-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$659,935.00
$30,980,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.03
$7.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.92
$1.24
52 Week High
$8.20
$3.86

Technical Indicators

Market Signals
Indicator
MYNZ
SSKN
Relative Strength Index (RSI) 53.56 37.69
Support Level $1.00 $1.29
Resistance Level $1.15 $1.37
Average True Range (ATR) 0.08 0.08
MACD 0.02 -0.00
Stochastic Oscillator 87.76 6.67

Price Performance

Historical Comparison
MYNZ
SSKN

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

About SSKN Strata Skin Sciences Inc.

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: